With the products not bundled the oxymorphone patch is worth no more than the BEMA. buprenorphine as a % of peak sales.
That does surprise me.
Again this is the independant valuation of the now disappeared oxycodone systemic patch"* Oxy C independent external valuation $500m post Phase II ** $900m post Phase III" from the 2013 agm slide.
Ultimately, even if POH get a $50mill up front it will keep the wheels turning.(is this the bargain basement deal you want Playez?) But where does. POH get the pay day? Is it a very hefty back end royalty attached to sales? With current specualtion I dont see how POH cashes in on having a mega blockbuster.
Is no one else willing to have a crack other than Jev and HT?
With the products not bundled the oxymorphone patch is worth no...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $68.62K | 33.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 36535232 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 43250695 | 24 |
View Market Depth
| Last trade - 13.47pm 09/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |